Top Analyst Reports for Novo Nordisk, TotalEnergies & U.S. Bancorp
Yahoo Finance · 3 days ago
Open | 143.07 |
High | 143.73 |
Low | 142.27 |
Mkt Cap | 636.43B |
P/E (TTM) | 49.27 |
Div & Yield | 1.37 & 0.96% |
Prev. Close | 142.40 |
52 Wk. Low | 75.56 |
52 Wk. High | 143.73 |
Related stocks
Danish pharmaceutical company
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd with production facilities in nine countries and affiliates or offices in five countries. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 65.35B | 22.50% ▲ |
Net Income | 25.41B | 28.20% ▲ |
Diluted EPS | 0.83 | 29.40% ▲ |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | $0.81 | - |
Q1 2024 | $0.75 | $0.83 |
Q4 2023 | $0.64 | $0.70 |
S&P FuturesES=F | 5,348.25-7.50 (-0.14%) |
Dow FuturesYM=F | 38,796.00-61.00 (-0.16%) |
Nasdaq FuturesNQ=F | 19,011.00-26.75 (-0.14%) |
120.89-0.08% | |
349.12+2.53% | |
308.21-3.54% |